| Charles Burger, MD | |
|
4500 San Pablo Rd S, Jacksonville, FL 32224-1865 | |
| (904) 953-2000 | |
| Not Available |
| Full Name | Charles Burger |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 39 Years |
| Location | 4500 San Pablo Rd S, Jacksonville, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790772671 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | ME57557 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Florida | Jacksonville, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic - Florida | 5698689297 | 1310 |
News Archive
Northwest Biotherapeutics, Inc. today announced further long-term follow-up data, for the period from January through September 2009, from its prior Phase I and Phase I/II clinical trials conducted at UCLA with DCVax®-Brain in patients with Glioblastoma multiforme ("GBM"). GBM is the most rapid and lethal type of brain cancer. During the update period, only one of the twenty patients treated with DCVax®-Brain (in addition to standard of care) died, and that patient had survived for nearly 7 years (80.5 months).
New research published in Cogent Psychology, examines the way sun safe messages are conveyed to young women, and reveals their vanity could play a vital role in protecting them from harmful UV light.
Self-employed Americans such as artists stand to gain under the health law, but rural residents may pay more for coverage because of the higher costs of delivering care in a sparsely populated area and the disproportionate number of older people. Other media outlets offer advice for consumers trying to make sense of the law.
Emerging therapies and promising new insights in the treatment of sickle cell disease represent a significant step toward improving outcomes and reducing the treatment burden for affected children and adults. Studies reporting these advances will be presented today at the 57th American Society of Hematology Annual Meeting and Exposition.
A team of researchers in California and Massachusetts has developed a "cocktail" of different nanometer-sized particles that work in concert within the bloodstream to locate, adhere to and kill cancerous tumors.
› Verified 1 days ago
| Entity Name | Mayo Clinic Jacksonville |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790772317 PECOS PAC ID: 5698689297 Enrollment ID: O20031118000388 |
News Archive
Northwest Biotherapeutics, Inc. today announced further long-term follow-up data, for the period from January through September 2009, from its prior Phase I and Phase I/II clinical trials conducted at UCLA with DCVax®-Brain in patients with Glioblastoma multiforme ("GBM"). GBM is the most rapid and lethal type of brain cancer. During the update period, only one of the twenty patients treated with DCVax®-Brain (in addition to standard of care) died, and that patient had survived for nearly 7 years (80.5 months).
New research published in Cogent Psychology, examines the way sun safe messages are conveyed to young women, and reveals their vanity could play a vital role in protecting them from harmful UV light.
Self-employed Americans such as artists stand to gain under the health law, but rural residents may pay more for coverage because of the higher costs of delivering care in a sparsely populated area and the disproportionate number of older people. Other media outlets offer advice for consumers trying to make sense of the law.
Emerging therapies and promising new insights in the treatment of sickle cell disease represent a significant step toward improving outcomes and reducing the treatment burden for affected children and adults. Studies reporting these advances will be presented today at the 57th American Society of Hematology Annual Meeting and Exposition.
A team of researchers in California and Massachusetts has developed a "cocktail" of different nanometer-sized particles that work in concert within the bloodstream to locate, adhere to and kill cancerous tumors.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles Burger, MD 4500 San Pablo Rd S, Jacksonville, FL 32224-1865 Ph: () - | Charles Burger, MD 4500 San Pablo Rd S, Jacksonville, FL 32224-1865 Ph: (904) 953-2000 |
News Archive
Northwest Biotherapeutics, Inc. today announced further long-term follow-up data, for the period from January through September 2009, from its prior Phase I and Phase I/II clinical trials conducted at UCLA with DCVax®-Brain in patients with Glioblastoma multiforme ("GBM"). GBM is the most rapid and lethal type of brain cancer. During the update period, only one of the twenty patients treated with DCVax®-Brain (in addition to standard of care) died, and that patient had survived for nearly 7 years (80.5 months).
New research published in Cogent Psychology, examines the way sun safe messages are conveyed to young women, and reveals their vanity could play a vital role in protecting them from harmful UV light.
Self-employed Americans such as artists stand to gain under the health law, but rural residents may pay more for coverage because of the higher costs of delivering care in a sparsely populated area and the disproportionate number of older people. Other media outlets offer advice for consumers trying to make sense of the law.
Emerging therapies and promising new insights in the treatment of sickle cell disease represent a significant step toward improving outcomes and reducing the treatment burden for affected children and adults. Studies reporting these advances will be presented today at the 57th American Society of Hematology Annual Meeting and Exposition.
A team of researchers in California and Massachusetts has developed a "cocktail" of different nanometer-sized particles that work in concert within the bloodstream to locate, adhere to and kill cancerous tumors.
› Verified 1 days ago
Dr. Jami Ann Rothe Kinnucan, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4500 San Pablo Rd S, Jacksonville, FL 32224 Phone: 904-953-2000 | |
Michelle Tulang, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4500 San Pablo Rd S, Jacksonville, FL 32224 Phone: 904-953-2000 | |
Dr. Minnsun Koh Park, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3900 University Blvd S, Jacksonville, FL 32216 Phone: 904-222-6656 | |
Sandrela Mussallam Abu Shaibeh, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 820 Prudential Dr Ste 304, Jacksonville, FL 32207 Phone: 904-202-3860 Fax: 904-202-3846 | |
Krunal Patel, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4800 Belfort Rd, Jacksonville, FL 32256 Phone: 904-398-7205 Fax: 904-396-4047 | |
Zaid Abdel Rahman, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 4500 San Pablo Rd S, Jacksonville, FL 32224 Phone: 904-953-2000 | |
Sina O'sullivan, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4500 San Pablo Rd S, Jacksonville, FL 32224 Phone: 904-953-2000 |